Renovascular hypertension in children Sami ArapFrancisco Tibor DénesLuiz Bortolotto Invited Commentary Pages: 181 - 182
Neoadjuvant androgen ablation before radical prostatectomy reduces positive margin rate, but has no effect on 36-month post-treatment biochemical failure Mitchell S. Steiner Clinical Trails Report Pages: 193 - 194
High grade prostatic intraepithelial neoplasia is a disease Mitchell S. Steiner OriginalPaper Pages: 195 - 198
Gene therapy for prostate cancer Jeffrey R. GingrichRavi D. ChauhanMitchell S. Steiner OriginalPaper Pages: 199 - 208
Incontinence after radical prostatectomy: Pathophysiology and management Scott A. MacDiarmid OriginalPaper Pages: 209 - 213
Does the CaverMap device help preserve potency? Hyung L. KimDeborah A. MhoonCharles B. Brendler OriginalPaper Pages: 214 - 217
How to improve prostate biopsy detection of prostate cancer David K. OrnsteinJohn Kang OriginalPaper Pages: 218 - 223
Secondary hormonal manipulation of prostate cancer Katherine A. HarrisEric J. Small OriginalPaper Pages: 224 - 230
The role of complementary medicine in the treatment of prostate cancer Ian YipNelida Duran OriginalPaper Pages: 231 - 236
Is it necessary to do staging pelvic lymph node dissection for T1c prostate cancer? Maxwell V. MengPeter R. Carroll OriginalPaper Pages: 237 - 241
Immunotherapy of prostate cancer Stephen J. FreedlandAllan J. PantuckArie S. Belldegrun OriginalPaper Pages: 242 - 247
Predicting continence following radical prostatectomy David W. MarshHerbert Lepor OriginalPaper Pages: 248 - 252
Complexed prostate-specific antigen improvement in detecting prostate cancer Koji OkiharaR. Joseph Babaian OriginalPaper Pages: 253 - 258